TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9482562

Group type: EXPERIMENTAL
Intervention: Combination of terfenadine and pseudoephedrine
Number of subjects: 41

Group type: COMPARATOR
Intervention: Terfenadine alone
Number of subjects: 41
Study: 8046193

Group type: EXPERIMENTAL
Intervention: Intervention group (physician-targeted treatment recommendations)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 175
Study: 3242386

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg x 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Estramustine (280 mg x 2)
Number of subjects: 30
Study: 31676298

Group type: EXPERIMENTAL
Intervention: Nursing care according to health promotion model
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group nursing care
Number of subjects: 80
Study: 30681707

Group type: EXPERIMENTAL
Intervention: $5 payment incentive
Number of subjects: 2275

Group type: EXPERIMENTAL
Intervention: $10 payment incentive
Number of subjects: 2275

Group type: EXPERIMENTAL
Intervention: $20 payment incentive
Number of subjects: 2275

Group type: COMPARATOR
Intervention: All payment groups
Number of subjects: 2275
Study: 27918744

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg + Esomeprazole 20 mg (NE)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Naproxen 500 mg
Number of subjects: 46
Study: 26353772

Group type: EXPERIMENTAL
Intervention: Combination therapy with S-1/irinotecan/bevacizumab (SIRB or IRIS/bevacizumab)
Number of subjects: 450
Study: 23937005

Group type: EXPERIMENTAL
Intervention: Malleus removal group (A)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Retaining only the malleus handle group (B)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Intact malleus group (C)
Number of subjects: 59
Study: 21219394

Group type: EXPERIMENTAL
Intervention: Water-cooled Nd:YAG laser (1064 nm, 6 W, 400 mJ) adjunctive to supra- and subgingival debridement (SRP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups (Nd:YAG laser and SRP alone)
Number of subjects: 19
Study: 19901211

Group type: EXPERIMENTAL
Intervention: Corticosteroid intervention
Number of subjects: 106
Study: 17434020

Group type: EXPERIMENTAL
Intervention: Low-sensitivity (LS) urine pregnancy tests
Number of subjects: 1080

Group type: EXPERIMENTAL
Intervention: High-sensitivity (HS) urine pregnancy tests
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Ultrasonography (control)
Number of subjects: 1080
Study: 15657568

Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Midazolam sedation
Number of subjects: 34
Study: 11167223

Group type: EXPERIMENTAL
Intervention: Evaluation of refraction using Nidek ARK 900 autorefracto‐keratometer
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Visual acuity tested on a Snellen chart
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Analysis of corneal astigmatism measured by keratometer
Number of subjects: 1045
Study: 9063317

Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (single-dose)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 19
Study: 8224684

Group type: EXPERIMENTAL
Intervention: Rectal endoscopic ultrasonography
Number of subjects: 20

Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 20
Study: 2878680

Group type: EXPERIMENTAL
Intervention: xamoterol 200 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: atenolol 50 mg
Number of subjects: 11
Study: 31594394

Group type: EXPERIMENTAL
Intervention: Leg press (LP) at 10 and 20 repetition maximum (RM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bench press (BeP) at 10 and 20 repetition maximum (RM)
Number of subjects: 10
Study: 29053185

Group type: EXPERIMENTAL
Intervention: High MLH1 expression levels
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Low MLH1 expression levels
Number of subjects: 117

Group type: COMPARATOR
Intervention: Both arms combined
Number of subjects: 117
Study: 27367832

Group type: EXPERIMENTAL
Intervention: d-cycloserine plus CBT
Number of subjects: 142

Group type: COMPARATOR
Intervention: placebo plus CBT
Number of subjects: 142
Study: 24735588

Group type: EXPERIMENTAL
Intervention: Acute geriatric ward (intervention group)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Orthopedic ward (control group)
Number of subjects: 329
Study: 23998557

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC) 2g/day orally for 4 months
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Propionyl-L-carnitine (PLC)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 20806094

Group type: COMPARATOR
Intervention: RelyX (RelyX Unicem; 3M ESPE)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: One-step (One-Step + Duo-link; Bisco)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Panavia F (ED primer + Panavia F; Kuraray)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Variolink II (Excite DSC + Variolink II; Ivoclar Vivadent)
Number of subjects: 44
Study: 17692951

Group type: EXPERIMENTAL
Intervention: ACEI
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: ACEI plus candesartan
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no ACEI or angiotensin receptor blocker)
Number of subjects: 128
Study: 16815780

Group type: EXPERIMENTAL
Intervention: Maximal exercise task
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Submaximal exercise task
Number of subjects: 24

Group type: COMPARATOR
Intervention: Resting control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both exercise tasks (maximal and submaximal)
Number of subjects: 24
Study: 12514657

Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF)
Number of subjects: 61041

Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) only at baseline
Number of subjects: 61041

Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) only after baseline
Number of subjects: 61041

Group type: EXPERIMENTAL
Intervention: Mild-to-moderate heart failure (HF) at baseline and later
Number of subjects: 61041

Group type: EXPERIMENTAL
Intervention: Presence of mild-to-moderate heart failure (HF)
Number of subjects: 61041
Study: 11594525

Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with total body irradiation (TBI) of 1200 cGy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with non-TBI regimen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unselected autoPBSCT with non-TBI regimen
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: CD34+ autoPBSCT with TBI
Number of subjects: 18
Study: 9196934

Group type: EXPERIMENTAL
Intervention: Topical dorzolamide hydrochloride (3 times a day and 5 times a day)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oral acetazolamide (2 weeks)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (4 weeks)
Number of subjects: 5
Study: 8466377

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (18 months duration, 14 weekly group meetings followed by monthly maintenance sessions)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 564

Group type: COMPARATOR
Intervention: Usual-care control condition
Number of subjects: 564
Study: 3803130

Group type: EXPERIMENTAL
Intervention: Graded esophageal balloon distention (10 cc total volume, inflated with 1-cc increments)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intraesophageal acid perfusion and intravenous edrophonium (80 micrograms/kg)
Number of subjects: 80
Study: 29436329

Group type: EXPERIMENTAL
Intervention: internet-based cognitive-behavioural therapy (iCBT) with protocol-driven therapist feedback
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: internet-based cognitive-behavioural therapy (iCBT) with feedback on demand
Number of subjects: 240

Group type: COMPARATOR
Intervention: waiting list
Number of subjects: 240
Study: 27999808

Group type: EXPERIMENTAL
Intervention: New algorithm for measuring compression depth and rate using two accelerometers
Number of subjects: 1

Group type: COMPARATOR
Intervention: Foam mattress with backboard
Number of subjects: 1

Group type: COMPARATOR
Intervention: Sprung mattress with backboard
Number of subjects: 1
Study: 24980650

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 41

Group type: COMPARATOR
Intervention: Walking Control
Number of subjects: 41
Study: 22486595

Group type: EXPERIMENTAL
Intervention: 12-week online ACT intervention
Number of subjects: 503

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Believability of Anxious Feelings and Thoughts Questionnaire (BAFT)
Number of subjects: 503
Study: 20533013

Group type: EXPERIMENTAL
Intervention: Closed-loop system for propofol administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual administration of propofol (Control)
Number of subjects: 40
Study: 18606952

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 13321

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 13321

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 13321

Group type: EXPERIMENTAL
Intervention: Acid-suppressing agents
Number of subjects: 13321

Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs
Number of subjects: 13321
Study: 16078807

Group type: EXPERIMENTAL
Intervention: Teleconferenced educational detailing (TED) CME
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 61
Study: 11549099

Group type: EXPERIMENTAL
Intervention: Cilomilast (Ariflo) 15 mg, single and repeat doses, taken before or between meals
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Cilomilast (Ariflo) 30 mg, repeat doses, taken after meals
Number of subjects: 5
Study: 9663727

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg daily
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg daily
Number of subjects: 169
Study: 7908358

Group type: EXPERIMENTAL
Intervention: Very-low-dose warfarin (1 mg daily for 6 weeks, adjusted to maintain INR of 1.3 to 1.9)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Very-low-dose warfarin
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Very-low-dose warfarin and Placebo
Number of subjects: 311
Study: 3043251

Group type: EXPERIMENTAL
Intervention: Isotonic non-ionic contrast medium, iohexol (omnipaque)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meglumine-sodium-diatrizoate (urografin)
Number of subjects: 0
Study: 1852753

Group type: EXPERIMENTAL
Intervention: Home Activity Assessment Tool
Number of subjects: 40
Study: 363751

Group type: EXPERIMENTAL
Intervention: Propoxyphene napsylate (P) 50 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Fenoprofen calcium (F) 600 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of P and F (P50 + F50)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of P and F (P200 + F50)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of P and F (P200 + F200)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combination of P and F (P200 + F600)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31678307

Group type: EXPERIMENTAL
Intervention: Robotic bronchoscopy (RB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Electromagnetic navigational bronchoscopy (EMN)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrathin bronchoscope with radial EBUS (UTB-rEBUS)
Number of subjects: 60
Study: 31018988

Group type: EXPERIMENTAL
Intervention: SBIRT (combined pediatrician and behavioral clinician arms)
Number of subjects: 1871

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1871
Study: 28410107

Group type: EXPERIMENTAL
Intervention: Feature Sensitive Label Fusion (FSLP) method for brain image segmentation
Number of subjects: 0
Study: 26209747

Group type: EXPERIMENTAL
Intervention: Weekly ergocalciferol (50,000 IU) supplementation
Number of subjects: 115
Study: 24102055

Group type: EXPERIMENTAL
Intervention: Green tea (3 cups daily for 14 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water regimen (control group)
Number of subjects: 0
Study: 21562068

Group type: EXPERIMENTAL
Intervention: ezetimibe/statin
Number of subjects: 21794

Group type: COMPARATOR
Intervention: statin
Number of subjects: 21794
Study: 19544246

Group type: EXPERIMENTAL
Intervention: Measured technique (N = 51)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Blind technique (N = 48)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 99
Study: 17921019

Group type: EXPERIMENTAL
Intervention: Baseline serum ferritin levels
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Dietary iron intake
Number of subjects: 824
Study: 15508793

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RFA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AA)
Number of subjects: 74
Study: 11557163

Group type: EXPERIMENTAL
Intervention: Haloperidol (2 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9272339

Group type: EXPERIMENTAL
Intervention: DTPwc vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTaP vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: DT vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stockholm I Trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Italian Trial
Number of subjects: 0
Study: 7930197

Group type: EXPERIMENTAL
Intervention: Three-dimensional echocardiography
Number of subjects: 35

Group type: COMPARATOR
Intervention: Two-dimensional echocardiography
Number of subjects: 35
Study: 3235234

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (for men)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sober (for women)
Number of subjects: 60
Study: 30974182

Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract extraction (PECE) by high-volume surgeons (more than 350 cases/year)
Number of subjects: 35880

Group type: EXPERIMENTAL
Intervention: Phacoemulsification cataract extraction (PECE)
Number of subjects: 35880

Group type: EXPERIMENTAL
Intervention: Small‐incision cataract surgery (SICS)
Number of subjects: 35880

Group type: EXPERIMENTAL
Intervention: Younger patient age
Number of subjects: 35880

Group type: EXPERIMENTAL
Intervention: Surgeon experience
Number of subjects: 35880
Study: 28093441

Group type: EXPERIMENTAL
Intervention: Premium brand name cigarettes
Number of subjects: 81

Group type: COMPARATOR
Intervention: Value brand name cigarettes
Number of subjects: 81
Study: 26269563

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication and treatment with antioxidants
Number of subjects: 976
Study: 22762359

Group type: EXPERIMENTAL
Intervention: Two small diameter implants (SDI) ‐ retained overdenture (study group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non‐intervention group (control group)
Number of subjects: 30
Study: 21511222

Group type: EXPERIMENTAL
Intervention: Bleeding (defined according to STEEPLE minor or major criteria)
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: Bleeding within 30 days
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: Bleeding after 30 days
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: Myocardial Infarction (MI)
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: MI within 30 days
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: MI after 30 days
Number of subjects: 3148
Study: 18463993

Group type: EXPERIMENTAL
Intervention: Dextromethorphan and quinidine (DM/Q) 30 mg/30 mg, twice a day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 17063976

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion (CIVS) of lorazepam
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bolus administration of lorazepam
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CIVS administration
Number of subjects: 13
Study: 14513074

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention program (moderate physical activity and diet changes for 3 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lean controls (baseline comparison)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Obese intervention group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Obese control group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study: 11311625

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 27

Group type: COMPARATOR
Intervention: PRK
Number of subjects: 27
Study: 9863096

Group type: EXPERIMENTAL
Intervention: Liangxue Piyan granule No. 2 (LPG)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Fufang Qingdai Capsule (FQC)
Number of subjects: 96
Study: 7929700

Group type: EXPERIMENTAL
Intervention: Tests of flexibility and programming (Spatial Learning with Self-Set Goals, Sorting)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cognition/Energy deficit on the Neurobehavioral Rating Scale
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Increased age
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Conventional intelligence tests
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Computed tomography findings
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Glasgow Coma Score
Number of subjects: 53
Study: 2459525

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31023352

Group type: EXPERIMENTAL
Intervention: Adolescent Cognitive Therapy for Anxiety (ACTA) - six 60-90 min sessions and a booster session
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group Cognitive Behaviour Therapy (CBT) - eight 2-h sessions and a booster session
Number of subjects: 48
Study: 29492934

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Diclofenac 75 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 26076096

Group type: EXPERIMENTAL
Intervention: Culturally specific intervention in preferred language
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Culturally specific intervention
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Materials in preferred language
Number of subjects: 222
Study: 23753523

Group type: EXPERIMENTAL
Intervention: Eccentric (ECC) exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged ECC training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged CONC training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whey protein supplementation
Number of subjects: 0
Study: 21970061

Group type: COMPARATOR
Intervention: Standard vocal therapy (Group I, n=33)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Larynx compression vocal therapy (Group II, n=33)
Number of subjects: 66
Study: 20160680

Group type: EXPERIMENTAL
Intervention: SAVI brachytherapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MammoSite brachytherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: 3D‐CRT
Number of subjects: 21
Study: 16445445

Group type: EXPERIMENTAL
Intervention: Acrysof Natural IOL (model SN60AT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Acrysof IOL (model SA60AT)
Number of subjects: 37
Study: 15536840

Group type: EXPERIMENTAL
Intervention: Bionator therapy (n = 14)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 25
Study: 11320947

Group type: EXPERIMENTAL
Intervention: Nutrition Education Program (NEP)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Mindfulness-based Stress Reduction Clinic Program (SRC)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual Supportive Care (UC)
Number of subjects: 172
Study: 9301391

Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 over 30 min (in males)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ringer's solution 25 ml kg‐1 over 30, 45, and 80 min (in females)
Number of subjects: 21
Study: 1376962

Group type: EXPERIMENTAL
Intervention: Bunazosin hydrochloride (1.5 mg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Bunazosin hydrochloride (3.0 mg/day)
Number of subjects: 35
Study: 3884469

Group type: EXPERIMENTAL
Intervention: Oral metoprolol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Injection sclerotherapy
Number of subjects: 32
Study: 30400725

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (OSS)
Number of subjects: 193

Group type: COMPARATOR
Intervention: 4-L polyethylene glycol (PEG)
Number of subjects: 193
Study: 29754811

Group type: EXPERIMENTAL
Intervention: Integrated Exposure Therapy and Exercise
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fall Prevention Education
Number of subjects: 42
Study: 27020000

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency potentiated with infrared light and fractional bipolar radiofrequency (combined approach)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (untreated quadrant)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination treatment (Bipolar radiofrequency potentiated with infrared light and fractional bipolar radiofrequency)
Number of subjects: 22
Study: 25004496

Group type: EXPERIMENTAL
Intervention: Psychological therapy for 12 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 32
Study: 21988617

Group type: EXPERIMENTAL
Intervention: Isoflavone (60 mg/day) for 12 months
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Isoflavone (60 mg/day)
Number of subjects: 158
Study: 19854632

Group type: EXPERIMENTAL
Intervention: Daily SMS reminder
Number of subjects: 26

Group type: COMPARATOR
Intervention: No SMS reminder (Control)
Number of subjects: 26
Study: 18030233

Group type: EXPERIMENTAL
Intervention: Bravo pH capsule
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nasally placed pH catheter
Number of subjects: 66
Study: 16118573

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) ingestion (4 mL.kg.15 min of 6%)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA) ingestion
Number of subjects: 15